Status:
COMPLETED
Intermittent Fasting Adherence and Self Tracking
Lead Sponsor:
University of Pennsylvania
Conditions:
Hypertension
Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot study will randomize 34 patients with hypertension and obesity to either time-restricted feeding alone or a commitment device to encourage time-restricted feeding, including a commitment pl...
Detailed Description
1.1. Non-Pharmacologic Interventions to Improve Blood Pressure Control: Despite the wide availability of multiple classes of antihypertensive agents, compelling data that blood pressure (BP) lowering ...
Eligibility Criteria
Inclusion
- Age 18 or older
- Body mass index \> 30 kg/m2
- Systolic blood pressure \> 150 mmHg
- Owns a smartphone or tablet operating the iOS or Android operating system
Exclusion
- Unable or unwilling to provide informed consent, including but not limited to cognitive or language barriers (reading or comprehension)
- Type 1 diabetes
- Use of insulin or insulin secretagogues (sulfonylureas, metaglinides)
- Use of medications that require food intake
- Ongoing use of pharmacologic therapy for weight loss
- Self-reported eating disorder
- Other medical condition that could be harmed by intermittent fasting as judged by study physician
- Anticipated life expectancy less than 6 months
- Any other reason why it is not feasible to complete the entire 6-month study
Key Trial Info
Start Date :
July 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2022
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT04836312
Start Date
July 12 2021
End Date
August 28 2022
Last Update
December 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104